SSSamuel Padovani Steffen

Samuel Padovani Steffen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Samuel Padovani Steffen has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mudança dos Padrões da Mortalidade Fora do Hospital e da Perda Prematura de Vida em Cardiomiopatias: Um Estudo Nacional Baseado em População

    by Alvaro Perazzo, Gabriel Kaleb Martins, Arina Peixoto Nobre, Arthur Línniker Lopes de Oliveira, Jose Roberto de Araújo Junior, Gabriela Lucena Montenegro, Carlos Eduardo Lucena Montenegro, Patricia Bezerra Rocha Montenegro, João Henrique Torres, Flavio Feijó, et al.

    Fundamento: As cardiomiopatias são uma importante causa de mortalidade cardiovascular, apresentando fenótipos dependentes da idade que variam desde morte súbita cardíaca (MSC) até insuficiência cardíaca progressiva. Apesar da queda nas taxas de mortalidade, lacunas na prevenção e no acesso a terapias avançadas podem se manifestar como mudanças no local do óbito e persistência de mortalidade prematura. Objetivos: Avaliar tendências temporais da mortalidade relacionada às cardiomiopatias no Brasil, examinar padrões etários no local do óbito e quantificar a mortalidade prematura por meio dos anos de vida perdidos (AVP). Métodos: Este estudo ecológico nacional, baseado em população, analisou 369 570 óbitos no Brasil (1996–2024) em que a cardiomiopatia (CID-10 I42) foi a causa básica. Tendências temporais foram avaliadas por regressão de Poisson, e associações entre idade e local do óbito foram estimadas por razões de chances (OR). Os AVP foram calculados utilizando tábuas de vida nacionais. Resultados: A mortalidade ajustada por idade diminuiu 1,7% ao ano (p<0,001). Óbitos hospitalares caíram de 75% para 43%, enquanto óbitos domiciliares aumentaram de 20% para 38%, com ponto de inflexão significativo por volta de 2011. Óbitos em vias públicas, usados como proxy de MSC, foram mais frequentes entre adultos de 20–39 anos (4,8%) do que entre aqueles com ≥60 anos (0,8%; OR 2,88; IC 95% 2,68–3,10). O total de AVP atingiu 6,83 milhões de anos. Indivíduos de 20–39 anos representaram apenas 5,5% dos óbitos, mas contribuíram com 12,8% dos AVP totais, com média de 42,9 anos perdidos por óbito. Conclusões: Apesar da queda na mortalidade, óbitos fora do ambiente hospitalar tornaram-se mais frequentes. O excesso de AVP entre adultos jovens evidencia lacunas na prevenção da MSC. Estratégias específicas por faixa etária são necessárias para reduzir a mortalidade prematura.

  • Open Access

    Shifting Patterns of Out-Of-Hospital Mortality and Premature Life Loss in Cardiomyopathies: A Nationwide Population-Based Study

    by Alvaro Perazzo, Gabriel Kaleb Martins, Arina Peixoto Nobre, Arthur Línniker Lopes de Oliveira, Jose Roberto de Araújo, Gabriela Lucena Montenegro, Carlos Eduardo Lucena Montenegro, Patricia Bezerra Rocha Montenegro, João Henrique Torres, Flavio Feijó, et al.

    Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based [...] Abstract Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based

  • Open Access

    Perioperative management of adult patients undergoing coronary artery bypass grafting and valve surgery: a literature review

    by Nair Naiara Barros de Vasconcelos, Veronica Neves Fialho Queiroz, Guilherme Martins de Souza, Sandrigo Mangini, Fernando Morita Fernandes Silva, Luiz Guilherme Villares da Costa, Pedro Paulo Zanella Do Amaral Campos, Samuel Padovani Steffen, Flávio Takaoka, Ary Serpa, et al.

    Purpose of review Coronary artery bypass grafting, revascularization by percutaneous coronary intervention, and heart valve surgery are crucial therapeutic interventions for patients with various cardiovascular diseases. The objective of this literature review was to present the main evidence and practical aspects of the perioperative management of patients undergoing coronary artery bypass grafting and heart valve surgery. Recent findings Despite advancements in surgical and anesthetic techniques, coronary artery bypass grafting and heart valve surgery present significant risks for perioperative complications


  • Open Access

    Gene expression analysis of primary graft dysfunction in adult heart transplant recipients: A cohort study

    by Samuel Padovani Steffen, Alvaro Monteiro Perazzo, Shirlyne Fabianni Dias Gaspar, Ronaldo Honorato Barros Santos, Domingos Dias Lourenço Filho, Alexandre da Costa Pereira, Luis Fernando B. da Costa Seguro, Fabiana G. Marcondes-Braga, Fernando Bacal, Jose Eduardo Krieger, et al.


  • Open Access

    Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction

    by Manuela Cristina Ribeiro Dias Barroso, Heleutério da Conceição Nicolau Madogolele, Danielle Louvet Guazzelli, Luis Fernando Bernal da Costa Seguro, Fabiana Goulart Marcondes-Braga, Sandrigo Mangini, Monica Samuel Ávila, Gabriel Barros Aulicino, Iascara Wozniak Campos, Samuel Padovani Steffen, et al.

    Introduction Cardiac sarcoidosis (CS) is an uncommon yet potentially life-threatening manifestation of systemic sarcoidosis. Recurrence of CS following heart transplantation (HTx) is an exceedingly rare event and presents a significant diagnostic challenge. […] Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction Introduction Cardiac sarcoidosis (CS) is an uncommon yet potentially life-threatening manifestation of systemic sarcoidosis. Recurrence of CS following heart transplantation (HTx) is an exceedingly rare event and presents a significant diagnostic challenge. […] Cardiac Sarcoidosis Reactivation in a Transplanted Heart: An Unusual Case of New Graft Dysfunction

  • Open Access

    Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto

    by Manuela Cristina Ribeiro Dias Barroso, Heleutério da Conceição Nicolau Madogolele, Danielle Louvet Guazzelli, Luis Fernando Bernal da Costa Seguro, Fabiana Goulart Marcondes-Braga, Sandrigo Mangini, Monica Samuel Ávila, Gabriel Barros Aulicino, Iascara Wozniak Campos, Samuel Padovani Steffen, et al.

    Introdução A sarcoidose cardíaca (SC) é uma manifestação incomum, porém potencialmente fatal, da sarcoidose sistêmica. A recorrência da SC após transplante cardíaco (TC) é um evento extremamente raro e representa um desafio diagnóstico significativo. […] Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto Introdução A sarcoidose cardíaca (SC) é uma manifestação incomum, porém potencialmente fatal, da sarcoidose sistêmica. A recorrência da SC após transplante cardíaco (TC) é um evento extremamente raro e representa um desafio diagnóstico significativo. […] Reativação da Sarcoidose Cardíaca em um Coração Transplantado: Um Caso Incomum de Nova Disfunção do Enxerto

  • Open Access

    History and Application of Mechanical Assist Devices as a Bridge to Heart Transplant: A Review and Perspectives in Brazil

    by Alvaro Perazzo, Fabio Antônio Gaiotto, Samuel Padovani Steffen, Shirlyne Fabianni Dias Gaspar Gaspar, Vanessa Simioni Faria, Rebeca Cavalcante Silva Ferreira, Aline Carbonera, Danielle Louvet Guazzelli, Jael Andrea Rioja Gamboa, Leonardo Flud Ideal, et al.

    Mechanical circulatory support (MCS) devices have evolved significantly over the past decades and play a vital role in managing end-stage heart failure, especially as a bridge to heart transplantation. From the pioneering heart-lung machines to third-generation ventricular assist devices (VADs), MCS technology has advanced to provide more durable, efficient, and safer options for both shortand long-term support. This review outlines the historical development of mechanical assist devices, the types of available supports - ranging from intra-aortic balloon pumps and extracorporeal membrane oxygenation to implantable devices like HeartMate 3 - and their clinical indications and complications. Special attention is given to right ventricular dysfunction, thromboembolic and hemorrhagic complications, and infections, which remain major challenges in the management of patients with MCS devices.In Brazil, despite the growing evidence supporting MCS in critically ill patients, access remains limited due to financial and systemic constraints. The review explores the current landscape of device availability in the country, national guidelines, cost-effectiveness data, and the impact of recent changes in transplant allocation criteria that prioritize patients receiving mechanical support. Notably, the approval of long-term VADs for destination therapy in the public health system in 2024 marks a significant milestone.This review offers a comprehensive perspective on MCS utilization, highlighting both global advances and Brazil-specific challenges. By identifying gaps in access and proposing future directions, it advocates for expanded use of these life-saving technologies to improve survival and quality of life in advanced heart failure patients.


  • Surgical Treatment of Cardiomyopathy

    by Lucas F. Cardoso, Samuel P. Steffen, Fabio A. Gaiotto

    Ischemic Cardiomyopathy Ischemic heart disease is the most common cause, and at the same time, it is the main isolated risk factor that favors the increased incidence of heart failure in the world. Several improvements incorporated in coronary artery bypass graft surgery have made the procedure safer and more effective, so patients who were previously candidates for heart transplants are now frequently revascularized. Hausmann et al. showed that, with the more comprehensive indication of myocardial revascularization in this scenario, patients [...] Ischemic Cardiomyopathy Ischemic heart disease is the most common cause, and at the same time, it is the main isolated risk factor that favors the increased incidence of heart failure in the world. Several improvements incorporated in coronary artery bypass graft surgery have made the procedure safer and more effective, so patients who were previously candidates for heart transplants are now frequently revascularized. Hausmann et al. showed that, with the more comprehensive indication of myocardial revascularization in this scenario, patients

  • Biologic Left Ventricular Assist: A New Strategy for Patients with Advanced Heart Failure with Pulmonary Hypertension

    by Fábio Antônio Gaiotto, Samuel Padovani Steffen

    Pulmonary arterial hypertension due to increased vascular resistance is a clinical condition that directly impacts the prognosis of patients with heart failure (HF), and it is considered one of the main contraindications to orthotopic heart transplantation. Although hemodynamic values vary in the literature, there is a consensus that pulmonary artery systolic pressure above 50 mmHg, transpulmonary gradient above 15 mmHg, and pulmonary vascular resistance above 3 Wood units, when unresponsive to vasodilators, contraindicate orthotopic transplantation. Therapeutic strategies to decrease or [...] Pulmonary arterial hypertension due to increased vascular resistance is a clinical condition that directly impacts the prognosis of patients with heart failure (HF), and it is considered one of the main contraindications to orthotopic heart transplantation. Although hemodynamic values vary in the literature, there is a consensus that pulmonary artery systolic pressure above 50 mmHg, transpulmonary gradient above 15 mmHg, and pulmonary vascular resistance above 3 Wood units, when unresponsive to vasodilators, contraindicate orthotopic transplantation. Therapeutic strategies to decrease or

  • Open Access

    First case of extracorporeal membrane oxygenation in cardiorespiratory arrest in an emergency room in Brasil: a possible reality?

    by Alexandre Soeiro, Tatiana Leal, Leonardo de Paula, Rony Lage, Priscila Goldstein, Thiago Scudeler, Gustavo Boros, Fábio Pedreira, Thiago Pereira, Thatiane Polastri, et al.

    The extracorporeal membrane oxygenation (ECMO) is a procedure that has been used for a long time in reference centers worldwide. Its fundamental precept is to serve as a bridge to a definitive treatment in patients with severe, but potentially reversible, clinical conditions. Despite this, its use in cardiopulmonary arrest (ECPR) is still a matter of debate, especially when indicated in the emergency department. There is not yet a sufficient level of evidence to support its routine use. In Brasil, the procedure stopped being considered an experimental technique by the Federal Council of Medicine only in 2017. The objective of the present case is to share the pioneering spirit of a Brazilian reference center with ECPR in the emergency room and to discuss the future challenges of the ECMO technique.